Literature DB >> 31254838

Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology.

Teruki Koizumi1, Takefumi Suzuki2, Nikhil Sasidharan Pillai3, Robert R Bies3, Hiroyoshi Takeuchi4, Kimio Yoshimura5, Masaru Mimura6, Hiroyuki Uchida7.   

Abstract

The objective of this study was to investigate possible circadian pattern of psychotic symptoms in patients with schizophrenia, which could be reflected on the dosing schedule/regimen, i.e. chrono-pharmacology. Patients with schizophrenia (ICD-10) who reported having auditory hallucination, receiving monotherapy with risperidone, olanzapine or paliperidone for at least two weeks were included. The subjects were provided a diary and asked to record the time and duration of auditory hallucinations during the eight time periods (i.e. 00:00-03:00, 03:00-06:00, 06:00-09:00, 09:00-12:00, 12:00-15:00, 15:00-18:00, 18:00-21:00, and 21:00-24:00). In the diary, times of medication doses and sleep were also recorded. Time and degree of peak and trough dopamine D2 receptor blockade with antipsychotics were estimated from 2 sparsely collected plasma drug concentrations. The prevalence and duration of auditory hallucinations were statistically examined among the eight time periods, respectively. Forty-nine patients participated in this study (mean ± SD age, 50.7 ± 14.8 years; 36 men (73.5%); 34 inpatients (69.4%)). Auditory hallucinations occurred most frequently and lasted for the longest duration in the period of 18:00-21:00 (75.5% (37/49) and 1.37 ± 1.67 h). This happened despite the fact that the difference in D2 receptor occupancy between the peak and trough was less than 2%, indicating a stable drug delivery. Since the dopamine D2 receptor blockade by antipsychotics was stable, the nocturnal circadian pattern found in this study may reflect intrinsic dopaminergic fluctuation or generally quieter environments at night. These circadian patterns may be considered to devise individualized treatment approach in the context of "chrono-pharmacology" for patients with schizophrenia.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antipsychotic; Dopamine; Dopamine D(2) receptor; Positron emission tomography; Schizophrenia

Year:  2019        PMID: 31254838     DOI: 10.1016/j.jpsychires.2019.06.019

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  1 in total

1.  When reason sleeps: attempted suicide during the circadian night.

Authors:  Andrew S Tubbs; Patricia Harrison-Monroe; Fabian-Xosé Fernandez; Michael L Perlis; Michael A Grandner
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.